Comparison with Similar Reports

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy...

Publisher:        MarketsandMarkets

# of Pages:        248

Rating: 

1 User License $4,950

Publication Date:  October, 2021

Price:       $4,950 / User License




1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED FOR THE STUDY 34
1.4 CURRENCY USED FOR THE STUDY 34
1.5 MAJOR MARKET STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Secondary sources 38
2.1.2 PRIMARY DATA 38
FIGURE 2 BREAKDOWN OF PRIMARIES: INFERTILITY TREATMENT MARKET 39
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 40
2.2.2 USAGE-BASED MARKET ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON PRODUCT UTILIZATION METHODOLOGY 41
FIGURE 5 MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON REVENUE MAPPING METHODOLOGY 42
2.2.3 PRIMARY RESEARCH VALIDATION 42
2.3 DATA TRIANGULATION 43
FIGURE 6 DATA TRIANGULATION METHODOLOGY 43
2.4 RESEARCH ASSUMPTIONS 44
2.5 RESEARCH LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 7 INFERTILITY TREATMENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 45
FIGURE 8 INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 46
FIGURE 9 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2021 VS. 2026 (USD MILLION) 47
FIGURE 10 INFERTILITY TREATMENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 48
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET 49
4 PREMIUM INSIGHTS 50
4.1 INFERTILITY TREATMENT MARKET OVERVIEW 50
FIGURE 12 DECLINING FERTILITY RATE AND RISING NUMBER OF FERTILITY CLINICS WORLDWIDE TO DRIVE MARKET GROWTH 50
4.2 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 51
FIGURE 13 MEDIA & CONSUMABLES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD 51
4.3 INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION) 52
FIGURE 14 ASSISTED REPRODUCTIVE TECHNOLOGY IS THE LARGEST PROCEDURE SEGMENT OF THE INFERTILITY TREATMENT MARKET 52
4.4 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION) 53
FIGURE 15 MALE INFERTILITY TREATMENT SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 53
4.5 INFERTILITY TREATMENT MARKET SHARE, BY END USER, 2021 54
FIGURE 16 FERTILITY CENTERS ARE THE LARGEST END USERS OF INFERTILITY TREATMENT PRODUCTS 54
4.6 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT AND COUNTRY (2021) 55
FIGURE 17 EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC INFERTILITY TREATMENT MARKET IN 2021 55
FIGURE 18 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026) 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 19 INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Declining fertility rate 58
FIGURE 20 DECLINING GLOBAL FERTILITY RATE, BY REGION, 1990 VS. 2019 VS. 2030 58
FIGURE 21 RISING OBESITY RATES (PERCENTAGE OF THE US POPULATION):
2010 VS. 2030 59
5.2.1.2 Rising number of fertility clinics worldwide 60
5.2.1.3 Technological advancements 60
5.2.1.3.1 Advancements in infertility treatment devices 60
5.2.1.3.2 Increasing use of time-lapse technology worldwide 61
5.2.1.4 Increasing public-private investments, funds, and grants 61
5.2.2 RESTRAINTS 62
5.2.2.1 High costs associated with assisted reproductive technology in developed markets 62
TABLE 1 INFERTILITY TREATMENT COSTS 62
5.2.2.2 Unsupportive government regulations 63

5.2.3 OPPORTUNITIES 64
5.2.3.1 Growth opportunities in emerging markets 64
5.2.3.1.1 Improving healthcare infrastructure 64
5.2.3.2 Increasing medical tourism due to low treatment costs 64
5.2.3.3 Use of fertility treatment options by single parents and same-sex couples 65
5.2.4 CHALLENGES 65
5.2.4.1 Concerns related to ART procedures 65
5.2.4.2 Reduced efficacy among older women 66
5.3 REGULATORY LANDSCAPE 66
5.3.1 NORTH AMERICA 66
5.3.1.1 US 66
5.3.1.2 Canada 67
5.3.2 EUROPE 67
5.3.3 ASIA PACIFIC 67
5.3.3.1 India 67
5.3.3.2 Japan 67
TABLE 2 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 68
5.4 COVID-19 IMPACT ON THE INFERTILITY TREATMENT MARKET 68
5.5 VALUE CHAIN ANALYSIS 69
FIGURE 22 VALUE CHAIN OF THE INFERTILITY TREATMENT MARKET 69
5.6 PRICING TREND ANALYSIS 70
TABLE 3 AVERAGE PRICE OF INFERTILITY TREATMENT EQUIPMENT AND MEDIA,
BY COUNTRY, 2020 (USD) 70
5.7 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 4 INFERTILITY TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 71
5.7.1 THREAT OF NEW ENTRANTS 71
FIGURE 23 THREAT OF NEW ENTRANTS 72
5.7.2 THREAT OF SUBSTITUTES 72
FIGURE 24 THREAT OF SUBSTITUTES 72
5.7.3 BARGAINING POWER OF SUPPLIERS 73
FIGURE 25 BARGAINING POWER OF SUPPLIERS 73
5.7.4 BARGAINING POWER OF BUYERS 73
FIGURE 26 BARGAINING POWER OF BUYERS 73
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 74
FIGURE 27 INTENSITY OF COMPETITIVE RIVALRY 74
5.8 ECOSYSTEM COVERAGE 74

6 INFERTILITY TREATMENT MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 5 INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 76
6.1.1 EQUIPMENT 76
TABLE 6 INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 77
TABLE 7 INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 77
6.2 MICROSCOPES 78
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF MICROSCOPY HAS RESULTED IN THE GROWING ADOPTION OF MICROSCOPES 78
TABLE 8 MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 78
TABLE 9 MICROSCOPES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 79
TABLE 10 MICROSCOPES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 79
TABLE 11 MICROSCOPES MARKET, BY END USER, 2019–2026 (USD MILLION) 80
6.2.2 IMAGING SYSTEMS 80
6.2.2.1 Advantages offered by imaging systems in the field of infertility treatment are driving their adoption 80
TABLE 12 IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 81
TABLE 13 IMAGING SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 81
TABLE 14 IMAGING SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 82
TABLE 15 IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 82
6.2.3 SPERM ANALYZER SYSTEMS 82
6.2.3.1 Sperm analyzer systems have a wide range of applications in fertility screening 82
TABLE 16 SPERM ANALYZER SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 83
TABLE 17 SPERM ANALYZER SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 83
TABLE 18 SPERM ANALYZER SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 84
TABLE 19 SPERM ANALYZER SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION) 84
6.2.4 OVUM ASPIRATION PUMPS 84
6.2.4.1 Ovum aspiration pumps are widely used to retrieve and protect oocytes 84
TABLE 20 OVUM ASPIRATION PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION) 85
TABLE 21 OVUM ASPIRATION PUMPS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 85
TABLE 22 OVUM ASPIRATION PUMPS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 86
TABLE 23 OVUM ASPIRATION PUMPS MARKET, BY END USER,
2019–2026 (USD MILLION) 86
6.2.5 MICROMANIPULATOR SYSTEMS 86
6.2.5.1 Micromanipulator systems are used in cases pertaining to poor sperm quality/mobility 86
TABLE 24 MICROMANIPULATOR SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 87
TABLE 25 MICROMANIPULATOR SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 88
TABLE 26 MICROMANIPULATOR SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 88
TABLE 27 MICROMANIPULATOR SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION) 89
6.2.6 INCUBATORS 89
6.2.6.1 Incubators play a vital role in embryo development and improved clinical outcomes 89
TABLE 28 INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 90
TABLE 29 INCUBATORS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 90
TABLE 30 INCUBATORS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 91
TABLE 31 INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 91
6.2.7 GAS ANALYZERS 91
6.2.7.1 Gas analyzers contain multiple ports enabling analysis of sequential gas samples 91
TABLE 32 GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 33 GAS ANALYZERS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 92
TABLE 34 GAS ANALYZERS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 93
TABLE 35 GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION) 93
6.2.8 LASER SYSTEMS 93
6.2.8.1 Common applications of laser systems include the treatment of stress urinary incontinence and vaginal tightening 93
TABLE 36 LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 37 LASER SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 94
TABLE 38 LASER SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 95
TABLE 39 LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 95
6.2.9 CRYOSYSTEMS 95
6.2.9.1 Demand for cryosystems is on the rise as women are seeking to extend their childbearing years 95
TABLE 40 CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 41 CRYOSYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 96
TABLE 42 CRYOSYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 97
TABLE 43 CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION) 97
6.2.10 SPERM SEPARATION DEVICES 98
6.2.10.1 Introduction of advanced sperm separation devices to boost their adoption 98
TABLE 44 SPERM SEPARATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 98
TABLE 45 SPERM SEPARATION DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 99
TABLE 46 SPERM SEPARATION DEVICES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 99
TABLE 47 SPERM SEPARATION DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 100
6.3 MEDIA & CONSUMABLES 100
6.3.1 EASY AVAILABILITY OF CULTURE MEDIA TO SUPPORT MARKET GROWTH 100
TABLE 48 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 101
TABLE 49 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 101
TABLE 50 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 102
TABLE 51 INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY END USER, 2019–2026 (USD MILLION) 102
6.4 ACCESSORIES 103
6.4.1 ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES 103
TABLE 52 INFERTILITY TREATMENT ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 103
TABLE 53 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 104
TABLE 54 INFERTILITY TREATMENT ACCESSORIES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 104
TABLE 55 INFERTILITY TREATMENT ACCESSORIES MARKET, BY END USER,
2019–2026 (USD MILLION) 105
7 INFERTILITY TREATMENT MARKET, BY PROCEDURE 106
7.1 INTRODUCTION 107
TABLE 56 INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 107
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY 107
TABLE 57 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 58 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION) 108
7.2.1 IN VITRO FERTILIZATION 108
FIGURE 28 UK: IVF BIRTH RATES, 2010–2019 109
TABLE 59 IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 60 IN VITRO FERTILIZATION MARKET, BY REGION, 2019–2026 (USD MILLION) 110
7.2.1.1 Intracytoplasmic morphologically selected sperm injection 110
7.2.1.1.1 IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure 110
TABLE 61 INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION MARKET, BY REGION, 2019–2026 (USD MILLION) 111
7.2.1.2 Gamete donation 111
7.2.1.2.1 Increasing number of women registering as egg donors is a key factor aiding market growth 111
TABLE 62 GAMETE DONATION MARKET, BY REGION, 2019–2026 (USD MILLION) 112
7.2.2 INTRACYTOPLASMIC SPERM INJECTION 112
7.2.2.1 ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures 112
TABLE 63 INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION,
2019–2026 (USD MILLION) 113
7.2.3 SURROGACY 113
7.2.3.1 High success rates guaranteed and achieved with the help of surrogacy are driving market growth 113
TABLE 64 SURROGACY MARKET, BY REGION, 2019–2026 (USD MILLION) 114
7.3 ARTIFICIAL INSEMINATION 114
TABLE 65 ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 66 ARTIFICIAL INSEMINATION MARKET, BY REGION, 2019–2026 (USD MILLION) 115
7.3.1 INTRAUTERINE INSEMINATION 116
7.3.1.1 Limited risk of complications during pregnancy and high success rate are driving the market for IUI procedures 116
TABLE 67 INTRAUTERINE INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 116
7.3.2 INTRACERVICAL INSEMINATION 117
7.3.2.1 Low cost of this procedure as compared to other AI procedures to support market growth 117
TABLE 68 INTRACERVICAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 117
7.3.3 INTRATUBAL INSEMINATION 117
7.3.3.1 High cost and uncertain success rate of this procedure to restrain the market growth 117
TABLE 69 INTRATUBAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION) 118
7.4 FERTILITY SURGERIES 118
TABLE 70 FERTILITY SURGERIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 71 FERTILITY SURGERIES MARKET, BY REGION, 2019–2026 (USD MILLION) 119
7.4.1 LAPAROSCOPY 119
7.4.1.1 Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility 119
TABLE 72 LAPAROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION) 120
7.4.2 HYSTEROSCOPY 120
7.4.2.1 Growing demand for minimally invasive procedures is driving the adoption of hysteroscopy infertility treatment surgeries globally 120
TABLE 73 HYSTEROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION) 121
7.4.3 MYOMECTOMY 121
7.4.3.1 Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery 121
TABLE 74 MYOMECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 122
7.4.4 LAPAROTOMY 122
7.4.4.1 Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system 122
TABLE 75 LAPAROTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 122
7.4.5 TUBAL LIGATION REVERSAL 123
7.4.5.1 Tubal ligation reversal is performed in women who still have a large portion of healthy fallopian tube remaining 123
TABLE 76 TUBAL LIGATION REVERSAL MARKET, BY REGION,
2019–2026 (USD MILLION) 123
7.4.6 VARICOCELECTOMY 124
7.4.6.1 Varicocelectomy results in a high chance of improved fertility with reduced complications 124
TABLE 77 VARICOCELECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 124
7.4.7 MICROSURGICAL RECONSTRUCTION 124
TABLE 78 MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 79 MICROSURGICAL RECONSTRUCTION MARKET, BY REGION,
2019–2026 (USD MILLION) 125
7.4.7.1 Vasovasostomy 125
7.4.7.1.1 Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men 125
TABLE 80 VASOVASOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 126
7.4.7.2 Vasoepididymostomy 126
7.4.7.2.1 Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI 126
TABLE 81 VASOEPIDIDYMOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION) 127
7.5 OTHER INFERTILITY TREATMENT PROCEDURES 127
TABLE 82 OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION,
2019–2026 (USD MILLION) 128
8 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE 129
8.1 INTRODUCTION 130
TABLE 83 INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 130
8.2 FEMALE INFERTILITY TREATMENT 130
8.2.1 INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET 130
FIGURE 29 US: IVF SUCCESS RATES BY AGE FOR ALL IVF CYCLES, 2019 131
TABLE 84 FEMALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 131
8.3 MALE INFERTILITY TREATMENT 132
8.3.1 GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO DRIVE MARKET GROWTH 132
TABLE 85 MALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 132

9 INFERTILITY TREATMENT MARKET, BY END USER 133
9.1 INTRODUCTION 134
TABLE 86 INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 134
9.2 FERTILITY CENTERS 134
9.2.1 GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE TO DRIVE MARKET GROWTH 134
TABLE 87 INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2019–2026 (USD MILLION) 135
9.3 HOSPITALS & SURGICAL CLINICS 135
9.3.1 GOVERNMENT INITIATIVES TO INCREASE HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES IS SUPPORTING MARKET GROWTH 135
TABLE 88 INFERTILITY TREATMENT MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2019–2026 (USD MILLION) 136
9.4 CRYOBANKS 136
9.4.1 INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT TO DRIVE MARKET GROWTH 136
TABLE 89 INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION,
2019–2026 (USD MILLION) 137
9.5 RESEARCH INSTITUTES 137
9.5.1 GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS TO DRIVE MARKET GROWTH 137
TABLE 90 INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 138
10 INFERTILITY TREATMENT MARKET, BY REGION 139
10.1 INTRODUCTION 140
TABLE 91 INFERTILITY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 140
10.2 ASIA PACIFIC 140
TABLE 93 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 142
TABLE 94 ASIA PACIFIC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 95 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 143
TABLE 96 ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 97 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 98 ASIA PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 99 ASIA PACIFIC: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 100 ASIA PACIFIC: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 101 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 146
TABLE 102 ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.2.1 CHINA 147
10.2.1.1 Declining birth rate in China to drive the demand for infertility treatment procedures in the country 147
TABLE 103 CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 104 CHINA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
10.2.2 JAPAN 148
10.2.2.1 Growing awareness has served to boost the adoption of IVF procedures in Japan 148
TABLE 105 JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 149
TABLE 106 JAPAN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
10.2.3 INDIA 150
10.2.3.1 Rising medical tourism to offer high-growth opportunities for players in the Indian infertility treatment market 150
TABLE 107 INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 108 INDIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
10.2.4 AUSTRALIA 152
10.2.4.1 Initiatives by the Australian government to support market growth 152
TABLE 109 AUSTRALIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 110 AUSTRALIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
10.2.5 SOUTH KOREA 154
10.2.5.1 Supportive government initiatives will positively impact market growth 154
TABLE 111 SOUTH KOREA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 112 SOUTH KOREA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
10.2.6 REST OF ASIA PACIFIC 155
TABLE 113 ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 114 ROAPAC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
10.3 EUROPE 157
TABLE 115 EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
TABLE 116 EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 158
TABLE 117 EUROPE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 118 EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 159
TABLE 119 EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 120 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 121 EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 122 EUROPE: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 123 EUROPE: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 124 EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 162
TABLE 125 EUROPE: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 162
10.3.1 GERMANY 162
10.3.1.1 Favorable funding scenario for IVF treatments in Germany to drive market growth 162
TABLE 126 GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 127 GERMANY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
10.3.2 UK 164
10.3.2.1 Supportive regulatory framework in the UK to drive market growth 164
FIGURE 31 UK: NUMBER OF IVF CYCLES BY EGG AND SPERM SOURCE, 2010-2019 165
TABLE 128 UK: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 129 UK: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
10.3.3 FRANCE 166
10.3.3.1 Rising healthcare spending in France to drive market growth 166
TABLE 130 FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 167
TABLE 131 FRANCE: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 168
10.3.4 ITALY 168
10.3.4.1 Decreasing fertility rates to drive the demand for fertility testing treatment procedures in Italy 168
TABLE 132 ITALY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 133 ITALY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
10.3.5 SPAIN 170
10.3.5.1 Spain is an established destination for IVF tourism 170
TABLE 134 SPAIN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 135 SPAIN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
10.3.6 REST OF EUROPE 171
TABLE 136 ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 172
TABLE 137 ROE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
10.4 NORTH AMERICA 173
TABLE 138 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 173
TABLE 139 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 140 NORTH AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 141 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 174
TABLE 142 NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 143 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 144 NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 145 NORTH AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 146 NORTH AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 177
TABLE 147 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 177
TABLE 148 NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 178
10.4.1 US 178
10.4.1.1 The US dominates the infertility treatment market in North America 178
TABLE 149 US: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 179
TABLE 150 US: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
10.4.2 CANADA 180
10.4.2.1 High cost of infertility treatment in the country to restrain the market growth 180
TABLE 151 CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 152 CANADA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
10.5 LATIN AMERICA 182
TABLE 153 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 182
TABLE 154 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 182
TABLE 155 LATIN AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 156 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 183
TABLE 157 LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 158 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 159 LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 160 LATIN AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 161 LATIN AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 162 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION) 186
TABLE 163 LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION) 187
10.5.1 BRAZIL 187
10.5.1.1 Brazil holds the largest share of the Latin American infertility treatment market 187
TABLE 164 BRAZIL: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 187
TABLE 165 BRAZIL: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
10.5.2 MEXICO 188
10.5.2.1 Growth in medical tourism is a key factor driving market growth 188
TABLE 166 MEXICO: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 189
TABLE 167 MEXICO: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
10.5.3 REST OF LATIN AMERICA 190
TABLE 168 ROLATAM: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 169 ROLATAM: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
10.6 MIDDLE EAST & AFRICA 191
10.6.1 RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 191
TABLE 170 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 192
TABLE 171 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 172 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 193
TABLE 173 MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 174 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 175 MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 176 MIDDLE EAST & AFRICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 177 MIDDLE EAST & AFRICA: MICROSURGICAL RECONSTRUCTION MARKET,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 178 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION) 196
TABLE 179 MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION) 197
11 COMPETITIVE LANDSCAPE 198
11.1 OVERVIEW 198
11.2 KEY PLAYER STRATEGIES 198
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 199
FIGURE 32 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 199
11.4 MARKET SHARE ANALYSIS (2020) 199
TABLE 180 INFERTILITY TREATMENT MARKET: DEGREE OF COMPETITION 199
11.5 COMPETITIVE LEADERSHIP MAPPING 201
11.5.1 STARS 201
11.5.2 PERVASIVE PLAYERS 201
11.5.3 EMERGING LEADERS 201
11.5.4 PARTICIPANTS 202
FIGURE 33 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2020 202
11.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020) 203
11.6.1 PROGRESSIVE COMPANIES 203
11.6.2 STARTING BLOCKS 203
11.6.3 RESPONSIVE COMPANIES 203
11.6.4 DYNAMIC COMPANIES 203
FIGURE 34 INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020 204
11.7 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 205
11.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET 205
TABLE 181 PRODUCT FOOTPRINT OF COMPANIES 206
11.8 COMPETITIVE SCENARIO 208
11.8.1 INFERTILITY TREATMENT MARKET: PRODUCT LAUNCHES AND
REGULATORY APPROVALS 208
TABLE 183 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY
2018–SEPTEMBER 2021 208
11.8.2 INFERTILITY TREATMENT MARKET: DEALS 208
TABLE 184 KEY DEALS, JANUARY 2018–SEPTEMBER 2021 208
11.8.3 INFERTILITY TREATMENT MARKET: OTHER DEVELOPMENTS 209
TABLE 185 OTHER KEY DEVELOPMENTS, JANUARY 2018–SEPTEMBER 2021 209
12 COMPANY PROFILES 210
12.1 MAJOR PLAYERS 210
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THE COOPER COMPANIES INC. 210
TABLE 186 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW 210
FIGURE 35 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020) 211
TABLE 187 THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS 212
12.1.2 COOK GROUP 214
TABLE 188 COOK GROUP: BUSINESS OVERVIEW 214
TABLE 189 COOK GROUP: PRODUCT OFFERINGS 214
12.1.3 VITROLIFE 216
TABLE 190 VITROLIFE: BUSINESS OVERVIEW 216
FIGURE 36 VITROLIFE: COMPANY SNAPSHOT (2020) 217
TABLE 191 VITROLIFE: PRODUCT OFFERINGS 218
12.1.4 THERMO FISHER SCIENTIFIC 220
TABLE 192 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 220
FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 221
TABLE 193 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 222
12.1.5 HAMILTON THORNE LTD. 224
TABLE 194 HAMILTON THORNE LTD.: BUSINESS OVERVIEW 224
FIGURE 38 HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020) 224
TABLE 195 HAMILTON THORNE LTD.: PRODUCT OFFERINGS 225
12.1.6 ESCO MICRO PTE. LTD. 227
TABLE 196 ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW 227
TABLE 197 ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS 227
12.1.7 GENEA LIMITED 229
TABLE 198 GENEA LIMITED: BUSINESS OVERVIEW 229
TABLE 199 GENEA LIMITED: PRODUCT OFFERINGS 229
12.1.8 IVFTECH APS 231
TABLE 200 IVFTECH APS: BUSINESS OVERVIEW 231
TABLE 201 IVFTECH APS: PRODUCT OFFERINGS 231
12.1.9 FUJIFILM IRVINE SCIENTIFIC 232
TABLE 202 FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW 232
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020) 232
TABLE 203 FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS 233
12.1.10 THE BAKER COMPANY, INC. 235
TABLE 204 THE BAKER COMPANY, INC.: BUSINESS OVERVIEW 235
TABLE 205 THE BAKER COMPANY, INC.: PRODUCT OFFERINGS 235
12.1.11 KITAZATO CORPORATION 236
TABLE 206 KITAZATO CORPORATION: BUSINESS OVERVIEW 236
TABLE 207 KITAZATO CORPORATION: PRODUCT OFFERINGS 236
12.1.12 ROCKET MEDICAL PLC 238
TABLE 208 ROCKET MEDICAL PLC: BUSINESS OVERVIEW 238
TABLE 209 ROCKET MEDICAL PLC: PRODUCT OFFERINGS 238
12.1.13 IHMEDICAL A/S 239
TABLE 210 IHMEDICAL A/S: BUSINESS OVERVIEW 239
TABLE 211 IHMEDICAL A/S: PRODUCT OFFERINGS 239
12.1.14 ZEISS GROUP 240
TABLE 212 ZEISS GROUP: BUSINESS OVERVIEW 240
FIGURE 40 ZEISS GROUP: COMPANY SNAPSHOT (2020) 241
TABLE 213 ZEISS GROUP: PRODUCT OFFERINGS 241
12.1.15 MEDGYN PRODUCTS, INC. 242
TABLE 214 MEDGYN PRODUCTS, INC.: BUSINESS OVERVIEW 242
TABLE 215 MEDGYN PRODUCTS, INC.: PRODUCT OFFERINGS 242
12.2 OTHER PLAYERS 234
12.2.1 DXNOW, INC. 234
12.2.2 NIDACON INTERNATIONAL AB 235
12.2.3 GYNOTEC B.V. 235
12.2.4 SAR HEALTHLINE PVT. LTD. 236
12.2.5 INVITROCARE INC. 237
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 247
13.1 DISCUSSION GUIDE 247
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 251
13.3 AVAILABLE CUSTOMIZATIONS 253
13.4 RELATED REPORTS 254
13.5 AUTHOR DETAILS 255

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47

3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107

10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170

10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31

3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56

7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88

9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127